Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Related Citations for PubMed (Select 22795751)

1.

Synthesis of benzamide derivatives and their evaluation as antiprion agents.

Fiorino F, Eiden M, Giese A, Severino B, Esposito A, Groschup MH, Perissutti E, Magli E, Incisivo GM, Ciano A, Frecentese F, Kretzschmar HA, Wagner J, Santagada V, Caliendo G.

Bioorg Med Chem. 2012 Aug 15;20(16):5001-11. doi: 10.1016/j.bmc.2012.06.026. Epub 2012 Jun 20.

PMID:
22795751
2.

Synthesis of analogues of Congo red and evaluation of their anti-prion activity.

Sellarajah S, Lekishvili T, Bowring C, Thompsett AR, Rudyk H, Birkett CR, Brown DR, Gilbert IH.

J Med Chem. 2004 Oct 21;47(22):5515-34.

PMID:
15481988
3.

Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.

Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC.

J Biol Chem. 2004 May 21;279(21):21948-56. Epub 2004 Mar 16.

4.

Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.

Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A.

Cell. 2003 Apr 4;113(1):49-60.

PMID:
12679034
5.

Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

Hosokawa-Muto J, Kamatari YO, Nakamura HK, Kuwata K.

Antimicrob Agents Chemother. 2009 Feb;53(2):765-71. doi: 10.1128/AAC.01112-08. Epub 2008 Nov 17.

6.

Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.

Miyamoto K, Nakamura N, Aosasa M, Nishida N, Yokoyama T, Horiuchi H, Furusawa S, Matsuda H.

Biochem Biophys Res Commun. 2005 Sep 16;335(1):197-204.

PMID:
16061207
7.

Elimination of prions by branched polyamines and implications for therapeutics.

Supattapone S, Nguyen HO, Cohen FE, Prusiner SB, Scott MR.

Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14529-34.

8.

Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Perrier V, Wallace AC, Kaneko K, Safar J, Prusiner SB, Cohen FE.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6073-8.

9.
10.

Prion clearance in bigenic mice.

Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P.

J Gen Virol. 2005 Oct;86(Pt 10):2913-23.

11.

Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects.

Klingenstein R, Melnyk P, Leliveld SR, Ryckebusch A, Korth C.

J Med Chem. 2006 Aug 24;49(17):5300-8.

PMID:
16913719
12.

Transfer of scrapie prion infectivity by cell contact in culture.

Kanu N, Imokawa Y, Drechsel DN, Williamson RA, Birkett CR, Bostock CJ, Brockes JP.

Curr Biol. 2002 Apr 2;12(7):523-30.

PMID:
11937020
13.

Discovery of a class of diketopiperazines as antiprion compounds.

Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, López-Cobeñas A, Bongarzone S, Biarnés X, López-Alvarado P, Cabezas N, Caramelli M, Carloni P, Menéndez JC, Legname G.

ChemMedChem. 2010 Aug 2;5(8):1324-34. doi: 10.1002/cmdc.201000133.

PMID:
20540064
14.

Antiprion activity of functionalized 9-aminoacridines related to quinacrine.

Nguyen TH, Lee CY, Teruya K, Ong WY, Doh-ura K, Go ML.

Bioorg Med Chem. 2008 Jul 15;16(14):6737-46. doi: 10.1016/j.bmc.2008.05.060. Epub 2008 Jun 13.

PMID:
18556207
15.

Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells.

Kimura T, Hosokawa-Muto J, Kamatari YO, Kuwata K.

Bioorg Med Chem Lett. 2011 Mar 1;21(5):1502-7. doi: 10.1016/j.bmcl.2010.12.132. Epub 2011 Jan 6.

PMID:
21277202
16.

Differential inhibition of prion propagation by enantiomers of quinacrine.

Ryou C, Legname G, Peretz D, Craig JC, Baldwin MA, Prusiner SB.

Lab Invest. 2003 Jun;83(6):837-43.

PMID:
12808118
17.
18.

Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie.

Solassol J, Crozet C, Perrier V, Leclaire J, Béranger F, Caminade AM, Meunier B, Dormont D, Majoral JP, Lehmann S.

J Gen Virol. 2004 Jun;85(Pt 6):1791-9.

19.

Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.

Pani A, Norfo C, Abete C, Mulas C, Putzolu M, Laconi S, Orrù CD, Cannas MD, Vascellari S, La Colla P, Dessì S.

Antimicrob Agents Chemother. 2007 Nov;51(11):4141-7. Epub 2007 Aug 20.

20.

Valproic acid treatment results in increased accumulation of prion proteins.

Shaked GM, Engelstein R, Avraham I, Rosenmann H, Gabizon R.

Ann Neurol. 2002 Oct;52(4):416-20.

PMID:
12325069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk